Shopping Cart
- Remove All
![TargetMol](https://www.targetmol.com/storage/error/oops.webp)
Your shopping cart is currently empty
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | IRAK4-IN-27 (Compound 22) is a potent and selective IRAK4 inhibitor, demonstrating an IC50 of 8.7 nM. It effectively suppresses cell growth and induces apoptosis in the MYD88 L265P diffuse large B-cell lymphoma (DLBCL) cell line, positioning it as a valuable agent for DLBCL research [1]. |
In vitro | IRAK4-IN-27 (Compound 22, 72 h) demonstrated antiproliferative activity in both MYD88 L265P DLBCL cell line (OCI-LY10, IC 50 = 0.248 μM) and MYD88 wild-type cell lines (U2932, IC 50 = 1.251 μM; and GM00637, IC 50 = 1.520 μM). IRAK4-IN-27 (0.5 μM and 1 μM, for 24 and 48 h, respectively) induced apoptosis in OCI-LY10 cells. The compound (0.03-3 μM) inhibited IRAK4 phosphorylation and subsequent signaling pathways in OCI-LY10 cells. Additionally, combination of IRAK4-IN-27 (0.1 μM and 0.2 μM, 48 h) with Ibrutinib suppressed OCI-LY10 cell growth and induced apoptosis. [1] |
Molecular Weight | 430.46 |
Formula | C23H22N6O3 |
Cas No. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.